Company intelligence / Profile preview
Hasco-Lek
- Ownership
- Private
- Employees
- ~969
- Development stage
- Other
Overview
Hasco-Lek is a leading Polish generic pharmaceutical manufacturer with over four decades of experience. The company produces a wide range of drugs—including OTC medicines—dietary supplements, cosmetics, and medical devices. It operates two manufacturing plants in Poland with EU-GMP certification and exports to Europe and Asia. Its portfolio includes more than 400 products across multiple therapeutic areas; it holds a top position in the Polish OTC market but does not develop novel therapeutics or proprietary platforms.
- Therapeutic areas
- Men's HealthRheumatologyCardiovascularImmunology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Hasco-Lek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hasco-Lek.